CORCEPT THERAPEUTICS INC Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2015 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Corcept Therapeutics Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2015 to Q3 2024.
  • Corcept Therapeutics Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 103M shares, a 1.33% increase year-over-year.
  • Corcept Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 104M shares, a 3.02% decline from 2022.
  • Corcept Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 107M shares, a 7.67% decline from 2021.
  • Corcept Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 116M shares, a 0.21% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 103M +1.36M +1.33% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 103M +1.15M +1.13% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-29
Q1 2024 103M -5.09M -4.72% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 104M -3.23M -3.02% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-15
Q3 2023 102M -5.11M -4.77% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 102M -4.33M -4.07% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-29
Q1 2023 108M +1.87M +1.77% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 107M -8.87M -7.67% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-15
Q3 2022 107M -8.67M -7.48% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 106M -10M -8.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 106M -10.8M -9.25% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 116M +241K +0.21% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-15
Q3 2021 116M +57K +0.05% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 116M +1.29M +1.12% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 117M +2.24M +1.96% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 115M +1.06M +0.93% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 116M +1.86M +1.63% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 115M +666K +0.58% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 115M -269K -0.23% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 114M -994K -0.86% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-15
Q3 2019 114M -1.92M -1.66% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-03
Q2 2019 114M -1.15M -1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 115M -38K -0.03% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-04
Q4 2018 115M +1.82M +1.6% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-23
Q3 2018 116M +2.2M +1.93% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 115M +2.24M +1.98% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 115M +2.02M +1.79% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 114M +2.96M +2.68% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-24
Q3 2017 114M +2.95M +2.67% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-02
Q2 2017 113M +3.22M +2.92% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 113M +3.21M +2.92% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 111M Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 111M +2.19M +2.02% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 110M +2.16M +2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 110M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-02
Q3 2015 108M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2015 108M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.